Granted Patent B2

US 8,435,497 · App. 10/559,383 · Granted May 7, 2013

Abstract

Claims (6)

1. A pharmaceutical suspension formulation comprising:

a) as a first active ingredient, particles of R,R-formoterol or a pharmaceutically acceptable salt thereof, said particles being suspended in the formulation,

b) as a second active ingredient, particles of ciclesonide or a pharmaceutically acceptable salt thereof, said particles being suspended in the formulation,

c) a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof, and

d) disodium cromoglycate at a concentration which is not therapeutically and/or prophylactically active,

wherein said first active ingredient and said second active ingredient are the sole active ingredients in said pharmaceutical suspension formulation, and are readily dispersible, and upon redispersion do not flocculate as to prevent reproducing dosing of said first active ingredient and/or said second active ingredient.

Assignments (20)